2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on HER2+ Curative Setting BC: Pertuzumab to SoC Trastuzumab vs. Utilizing T-DM1 for Pts w/ Residual Disease vs. Extending Adjuvant Tx With 1 yr of Neratinib?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Reshma L. Mahtani
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Reshma L. Mahtani
0 views
July 16, 2020
Comments 1
Login to view comments.
Click here to Login
Breast